Overview Powered by AI
Ohara Pharmaceutical, a leading healthcare investor, specializes in Series A funding across Africa. With a focus on transformative startups like Helium Health, they identify promising businesses and empower them to improve healthcare outcomes on the continent. Their deep understanding of the region sets them apart, enabling them to make strategic investments that drive innovation and impact.
Ohara Pharmaceutical's Latest news
Japanβs Ohara Pharmaceutical takes over 20% stake in Fidson Healthcare - Nairametrics
EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical - PR Newswire
| Round | Startup | Location | Date | Amount Raised |
|---|---|---|---|---|
| Series A | Nigeria | Apr 30, 2020 | $ 10,000,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 |
Upgrade to StartupList Africa PRO for unlimited access to this list.
lockUnlock Access to Full ListUnlock more Data
Access more Data and functionalities with our PRO plan.